Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1980 Dec;42(6):881–889. doi: 10.1038/bjc.1980.336

Cytotoxicity of adriamycin to tumour cells in vivo and in vitro.

W M Martin, N J McNally
PMCID: PMC2010572  PMID: 7459222

Abstract

Two mouse sarcomas have been used to assess the sensitivity to Adriamycin of tumour cells in vivo and in vitro. Both tumours were tissue-culture adapted so that cell survival could be assayed in vitro after treatment either in vivo or in vitro. For both tumours (WHFIB and CBSAF) cells were highly sensitive when treated in vitro yet very resistant to treatment in vivo, whether assayed by cell survival or regrowth delay. Cells from both tumours treated in vitro with Adriamycin immediately after excision were slightly more resistant than the cells maintained in vitro. However, this was not adequate to explain the marked discrepancy between in vivo resistance and in vitro sensitivity. The discrepancy was not due to a failure of drug delivery. Phase of cell growth was the factor was most significantly affecting chemosensitivity in vitro, plateau-phase cells being much more resistant than log-phase cells. Hypoxia was also an important factor leading to reduced chemosensitivity. Tumour diameter, in the range 2-8 mm, did not appear to be important.

Full text

PDF
881

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Balconi G., Bossi A., Donelli M. G., Filippeschi S., Franchi G., Morasca L., Garattini S. Chemotherapy of a spontaneous mammary carcinoma in mice: relation between in vitro-in vivo activity and blood and tumor concentrations of serveral antitumor drugs. Cancer Chemother Rep. 1973 Apr;57(2):115–124. [PubMed] [Google Scholar]
  2. Barranco S. C., Gerner E. W., Burk K. H., Humphrey R. M. Survival and cell kinetics effects of adriamycin on mammalian cells. Cancer Res. 1973 Jan;33(1):11–16. [PubMed] [Google Scholar]
  3. Belli J. A., Piro A. J. The interaction between radiation and adriamycin damage in mammalian cells. Cancer Res. 1977 Jun;37(6):1624–1630. [PubMed] [Google Scholar]
  4. Benjamin R. S., Wiernik P. H., Bachur N. R. Adriamycin chemotherapy--efficacy, safety, and pharmacologic basis of an intermittent single high-dosage schedule. Cancer. 1974 Jan;33(1):19–27. doi: 10.1002/1097-0142(197401)33:1<19::aid-cncr2820330107>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  5. Carter S. K. Adriamycin-a review. J Natl Cancer Inst. 1975 Dec;55(6):1265–1274. doi: 10.1093/jnci/55.6.1265. [DOI] [PubMed] [Google Scholar]
  6. Carter S. K., Livingston R. B. Single-agent therapy for Hodgkin's disease. Arch Intern Med. 1973 Mar;131(3):377–387. [PubMed] [Google Scholar]
  7. Carter S. K. Single and combination nonhormonal chemotherapy in breast cancer. Cancer. 1972 Dec;30(6):1543–1555. doi: 10.1002/1097-0142(197212)30:6<1543::aid-cncr2820300621>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  8. Chan K. K., Harris P. A. A fluorometric determination of adriamycin and its metabolites in biological tissues. Res Commun Chem Pathol Pharmacol. 1973 Sep;6(2):447–463. [PubMed] [Google Scholar]
  9. Edwards F. H., Coffey C. W., 2nd A cumulative normal distribution model for simulation of electron beam profiles. Int J Radiat Oncol Biol Phys. 1979 Jan;5(1):127–133. doi: 10.1016/0360-3016(79)90051-8. [DOI] [PubMed] [Google Scholar]
  10. Fu K. K., Begg A. B., Kane L. J., Phillips T. L. Interaction of radiation and adriamycin on the EMT6 tumor as a function of tumor size and assay method. Int J Radiat Oncol Biol Phys. 1979 Aug;5(8):1249–1254. doi: 10.1016/0360-3016(79)90648-5. [DOI] [PubMed] [Google Scholar]
  11. George K. C., Hirst D. G., McNally N. J. Effect of hyperthermia on cytotoxicity of the radiosensitizer Ro-07-0582 in a solid mouse tumour. Br J Cancer. 1977 Mar;35(3):372–375. doi: 10.1038/bjc.1977.52. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gottlieb J. A., Rivkin S. E., Spigel S. C., Hoogstraten B., O'Bryan R. M., Delaney F. C., Singhakowinta A. Proceedings: Superiority of adriamycin over oral nitrosoureas in patients with advanced breast carcinoma. A Southwest Cancer Chemotherapy study Group study. Cancer. 1974 Feb;33(2):519–526. doi: 10.1002/1097-0142(197402)33:2<519::aid-cncr2820330229>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  13. Hahn G. M., Li G. C., Shiu E. Interaction of amphotericin B and 43 degrees hyperthermia. Cancer Res. 1977 Mar;37(3):761–764. [PubMed] [Google Scholar]
  14. Harris J. W., Shrieve D. C. Effects of adriamycin and X-rays on euoxic and hypoxic EMT-6 cells in vitro. Int J Radiat Oncol Biol Phys. 1979 Aug;5(8):1245–1248. doi: 10.1016/0360-3016(79)90647-3. [DOI] [PubMed] [Google Scholar]
  15. Kim S. H., Kim J. H. Lethal effect of adriamycin on the division cycle of HeLa cells. Cancer Res. 1972 Feb;32(2):323–325. [PubMed] [Google Scholar]
  16. Roizin-Towle L., Hall E. J. Studies with bleomycin and misonidazole on aerated and hypoxic cells. Br J Cancer. 1978 Feb;37(2):254–260. doi: 10.1038/bjc.1978.34. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Rosen G., Suwansirikul S., Kwon C., Tan C., Wu S. J., Beattie E. J., Jr, Murphy M. L. High-dose methotrexate with citrovorum factor rescue and adriamycin in childhood osteogenic sarcoma. Cancer. 1974 Apr;33(4):1151–1163. doi: 10.1002/1097-0142(197404)33:4<1151::aid-cncr2820330439>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  18. Shipley W. U., Stanley J. A., Steel G. G. Tumor size dependency in the radiation response of the Lewis lung carcinoma. Cancer Res. 1975 Sep;35(9):2488–2493. [PubMed] [Google Scholar]
  19. Smith E., Stratford I. J., Adams G. E. Cytotoxicity of adriamycin on aerobic and hypoxic chinese hamster V79 cells in vitro. Br J Cancer. 1980 Oct;42(4):568–573. doi: 10.1038/bjc.1980.281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Steel G. G., Adams K., Stanley J. Size dependence of the response of Lewis lung tumors to BCNU. Cancer Treat Rep. 1976 Dec;60(12):1743–1748. [PubMed] [Google Scholar]
  21. Sutherland R. M., Eddy H. A., Bareham B., Reich K., Vanantwerp D. Resistance to adriamycin in multicellular spheroids. Int J Radiat Oncol Biol Phys. 1979 Aug;5(8):1225–1230. doi: 10.1016/0360-3016(79)90643-6. [DOI] [PubMed] [Google Scholar]
  22. Twentyman P. R. Sensitivity to cytotoxic agents of the EMT6 tumour in vivo: tumour volume versus in vitro plating. 1. Cyclophosphamide. Br J Cancer. 1977 Feb;35(2):208–217. doi: 10.1038/bjc.1977.28. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES